ZA964082B - Stable, concentrated, locally tolerated erythromycylamine solutions - Google Patents

Stable, concentrated, locally tolerated erythromycylamine solutions

Info

Publication number
ZA964082B
ZA964082B ZA964082A ZA964082A ZA964082B ZA 964082 B ZA964082 B ZA 964082B ZA 964082 A ZA964082 A ZA 964082A ZA 964082 A ZA964082 A ZA 964082A ZA 964082 B ZA964082 B ZA 964082B
Authority
ZA
South Africa
Prior art keywords
erythromycylamine
concentrated
solutions
stable
tolerated
Prior art date
Application number
ZA964082A
Inventor
Stefan Leiner
Werner Schleicher
Bernhard Hassel
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of ZA964082B publication Critical patent/ZA964082B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA964082A 1995-05-23 1996-05-22 Stable, concentrated, locally tolerated erythromycylamine solutions ZA964082B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19518917A DE19518917A1 (en) 1995-05-23 1995-05-23 Stable, concentrated, locally tolerated erythromycylamine solutions

Publications (1)

Publication Number Publication Date
ZA964082B true ZA964082B (en) 1996-11-22

Family

ID=7762671

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964082A ZA964082B (en) 1995-05-23 1996-05-22 Stable, concentrated, locally tolerated erythromycylamine solutions

Country Status (6)

Country Link
AR (1) AR002069A1 (en)
AU (1) AU5898296A (en)
DE (1) DE19518917A1 (en)
IL (1) IL118381A0 (en)
WO (1) WO1996037190A1 (en)
ZA (1) ZA964082B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA695765B (en) * 1968-08-29 1971-03-31 Lilly Co Eli Erythromycylamine and process for preparing same
ZA71763B (en) * 1970-04-13 1972-03-29 Lilly Industries Ltd Erythromycylamines via hydrazones
IL81395A0 (en) * 1986-02-03 1987-08-31 Lilly Co Eli Novel derivatives of erythromycylamine
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
DE4410637C1 (en) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injectable solutions of dirithromycin

Also Published As

Publication number Publication date
AR002069A1 (en) 1998-01-07
IL118381A0 (en) 1996-09-12
DE19518917A1 (en) 1996-11-28
WO1996037190A1 (en) 1996-11-28
AU5898296A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
ZA961444B (en) Pyrazolylbenzoyl derivatives.
ZA967315B (en) Biphenylamides.
AU6298694A (en) Insecticidal substituted-2,4-diaminoquinazolines
MX213417B (en) Phenylpyridazinones.
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
ZA964468B (en) Triazolylmethyl-cyclopentanols.
ZA961955B (en) Indazolecarboxamides.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
EP0654534A3 (en) Processes for producing optically active 2-amino-1-phenylethanol derivatives.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA96960B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
ZA967741B (en) Diarylalkenylamine derivatives.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA967545B (en) Pharmaceuticals.
ZA964082B (en) Stable, concentrated, locally tolerated erythromycylamine solutions
ZA966396B (en) Boronic acid derivatives.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA966750B (en) Halogenobenzimidazoles.
ZA964034B (en) N-aminopyridone derivatives.
ZA967314B (en) Carbamoylcarboxamides.
ZA965713B (en) 5-pyrazolylbenzoic acid derivatives.